565 related articles for article (PubMed ID: 33718434)
1. Drug Repurposing Strategy (DRS): Emerging Approach to Identify Potential Therapeutics for Treatment of Novel Coronavirus Infection.
Sahoo BM; Ravi Kumar BVV; Sruti J; Mahapatra MK; Banik BK; Borah P
Front Mol Biosci; 2021; 8():628144. PubMed ID: 33718434
[TBL] [Abstract][Full Text] [Related]
2. Computational Approach to Combat COVID-19 Infection: Emerging Tools for Accelerating Drug Research.
Sahoo BM; Bhattamisra SK; Das S; Tiwari A; Tiwari V; Kumar M; Singh S
Curr Drug Discov Technol; 2022; 19(3):e170122200314. PubMed ID: 35040405
[TBL] [Abstract][Full Text] [Related]
3. Drug repurposing in COVID-19: A review with past, present and future.
Srivastava K; Singh MK
Metabol Open; 2021 Dec; 12():100121. PubMed ID: 34462734
[TBL] [Abstract][Full Text] [Related]
4. Drug repurposing using computational methods to identify therapeutic options for COVID-19.
Mahdian S; Ebrahim-Habibi A; Zarrabi M
J Diabetes Metab Disord; 2020 Dec; 19(2):691-699. PubMed ID: 32837954
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking and Virtual Screening.
Chtita S; Belhassan A; Aouidate A; Belaidi S; Bouachrine M; Lakhlifi T
Comb Chem High Throughput Screen; 2021; 24(3):441-454. PubMed ID: 32748740
[TBL] [Abstract][Full Text] [Related]
6. Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review.
Santos J; Brierley S; Gandhi MJ; Cohen MA; Moschella PC; Declan ABL
Viruses; 2020 Jun; 12(7):. PubMed ID: 32629804
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Effectiveness and Safety of Repurposing Drugs for the Treatment of COVID-19: Position Standing in 2021.
Alam S; Kamal TB; Sarker MMR; Zhou JR; Rahman SMA; Mohamed IN
Front Pharmacol; 2021; 12():659577. PubMed ID: 34220503
[TBL] [Abstract][Full Text] [Related]
8. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
Kumar Y; Singh H; Patel CN
J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
[TBL] [Abstract][Full Text] [Related]
9. A review on drug repurposing in COVID-19: from antiviral drugs to herbal alternatives.
Sezer A; Halilović-Alihodžić M; Vanwieren AR; Smajkan A; Karić A; Djedović H; Šutković J
J Genet Eng Biotechnol; 2022 May; 20(1):78. PubMed ID: 35608704
[TBL] [Abstract][Full Text] [Related]
10. Molecular Binding Mechanism and Pharmacology Comparative Analysis of Noscapine for Repurposing against SARS-CoV-2 Protease.
Kumar N; Sood D; van der Spek PJ; Sharma HS; Chandra R
J Proteome Res; 2020 Nov; 19(11):4678-4689. PubMed ID: 32786685
[TBL] [Abstract][Full Text] [Related]
11. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
Shoaib M; Kamal MA; Rizvi SMD
Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
[TBL] [Abstract][Full Text] [Related]
12. Molecular Pathogenesis, Immunopathogenesis and Novel Therapeutic Strategy Against COVID-19.
Chatterjee SK; Saha S; Munoz MNM
Front Mol Biosci; 2020; 7():196. PubMed ID: 32850977
[TBL] [Abstract][Full Text] [Related]
13. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
14. Drug Repurposing Approach against Novel Coronavirus Disease (COVID-19) through Virtual Screening Targeting SARS-CoV-2 Main Protease.
Chowdhury KH; Chowdhury MR; Mahmud S; Tareq AM; Hanif NB; Banu N; Reza ASMA; Emran TB; Simal-Gandara J
Biology (Basel); 2020 Dec; 10(1):. PubMed ID: 33374717
[TBL] [Abstract][Full Text] [Related]
15. Identification of a druggable binding pocket in the spike protein reveals a key site for existing drugs potentially capable of combating Covid-19 infectivity.
Drew ED; Janes RW
BMC Mol Cell Biol; 2020 Jul; 21(1):49. PubMed ID: 32611313
[TBL] [Abstract][Full Text] [Related]
16. Computational drug repurposing strategy predicted peptide-based drugs that can potentially inhibit the interaction of SARS-CoV-2 spike protein with its target (humanACE2).
Egieyeh S; Egieyeh E; Malan S; Christofells A; Fielding B
PLoS One; 2021; 16(1):e0245258. PubMed ID: 33417604
[TBL] [Abstract][Full Text] [Related]
17. Identification of a repurposed drug as an inhibitor of Spike protein of human coronavirus SARS-CoV-2 by computational methods.
Unni S; Aouti S; Thiyagarajan S; Padmanabhan B
J Biosci; 2020; 45(1):. PubMed ID: 33184246
[TBL] [Abstract][Full Text] [Related]
18. Potential Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 606 Million Compounds.
Fischer A; Sellner M; Neranjan S; Smieško M; Lill MA
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455534
[TBL] [Abstract][Full Text] [Related]
19. An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.
Gudadappanavar AM; Benni J
J Basic Clin Physiol Pharmacol; 2020 Sep; 31(6):. PubMed ID: 32924964
[TBL] [Abstract][Full Text] [Related]
20. A High-Throughput Screening Approach To Repurpose FDA-Approved Drugs for Bactericidal Applications against Staphylococcus aureus Small-Colony Variants.
Trombetta RP; Dunman PM; Schwarz EM; Kates SL; Awad HA
mSphere; 2018 Oct; 3(5):. PubMed ID: 30381352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]